Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ceska

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Vnitrni Lekarstvi|May 10, 2001
[Therapeutic goals in hyperlipoproteinemia]R Ceska
Vnitrni Lekarstvi|March 1, 1995
[Pharmacotherapy of hyperlipoproteinemia in view of the newest European and American recommendations]R Ceska
Vnitrni Lekarstvi|August 1, 1996
[Fluvastatin in the treatment of hyperlipoproteinemia, initial experience]R Ceska
Vnitrni Lekarstvi|February 1, 1993
[Pharmacologic therapy of hyperlipoproteinemia and its pitfalls]R Ceska
Casopis Lekaru Ceskych|November 21, 1994
[Familial apolipoprotein B-100 defect, a newly discovered lipid metabolism disorder]R Ceska
Vnitrni Lekarstvi|August 1, 1996
[Treatment of hyperlipoproteinemia in clinical practice]R Ceska
Casopis Lekaru Ceskych|April 10, 1992
[Diseases of civilization from the aspect of evolution of the human diet]J Sobra, R Ceska
Physiological Research|September 13, 2000
Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosisB Horejsí, R Ceska
Vnitrni Lekarstvi|October 1, 1989
[Gemfibrozil in the treatment of hyperlipoproteinemia]R Ceska, J Sobra
Vnitrni Lekarstvi|August 19, 2007
[Is familial hypercholesterolemia under control in the Czech Republic?]T Freiberger, R Ceska
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Vnitrni Lekarstvi|May 10, 2001
[Therapeutic goals in hyperlipoproteinemia]R Ceska
Vnitrni Lekarstvi|March 1, 1995
[Pharmacotherapy of hyperlipoproteinemia in view of the newest European and American recommendations]R Ceska
Vnitrni Lekarstvi|August 1, 1996
[Fluvastatin in the treatment of hyperlipoproteinemia, initial experience]R Ceska
Vnitrni Lekarstvi|February 1, 1993
[Pharmacologic therapy of hyperlipoproteinemia and its pitfalls]R Ceska
Casopis Lekaru Ceskych|November 21, 1994
[Familial apolipoprotein B-100 defect, a newly discovered lipid metabolism disorder]R Ceska
Vnitrni Lekarstvi|August 1, 1996
[Treatment of hyperlipoproteinemia in clinical practice]R Ceska
Casopis Lekaru Ceskych|April 10, 1992
[Diseases of civilization from the aspect of evolution of the human diet]J Sobra, R Ceska
Physiological Research|September 13, 2000
Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosisB Horejsí, R Ceska
Vnitrni Lekarstvi|October 1, 1989
[Gemfibrozil in the treatment of hyperlipoproteinemia]R Ceska, J Sobra
Vnitrni Lekarstvi|August 19, 2007
[Is familial hypercholesterolemia under control in the Czech Republic?]T Freiberger, R Ceska
Pageof 12